Fundraising Fox

Caladrius Biosciences

NASDAQ: LSTA

Basking Ridge, US · Delaware corporation

Biotech

Founders & leadership

DJ
David J. MazzoExecutive
JT
Joseph TalamoExecutive
RA
Robert A. PretiExecutive
AL
Andrew L. PecoraExecutive
RP
Robert PretiNamed on SEC filing
SW
Stephen W. PotterNamed on SEC filing
MD
Martyn D. GreenacreNamed on SEC filing
RD
Robert Dickey IVNamed on SEC filing
CV
Catherine VaczyNamed on SEC filing
DL
Douglas LosordoNamed on SEC filing
DB
Drew BernsteinNamed on SEC filing
EH
Eric H.C. WeiNamed on SEC filing

Reported raises · per SEC filings

Form D private placements

$83.2M disclosed across 7 rounds · 2014–2021

▶$25MraisedFeb 2021 · 23 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Steven M. KloskDirector
  • Gregory B. BrownDirector
  • Steven S. MyersDirector
  • Cynthia SchwalmDirector
  • Peter G. TraberDirector
  • Anne WhitakerDirector
  • David J. MazzoExecutive Officer, Director
  • Michael DavidsonDirector
Offering amount
$25M
Amount sold
$25M
Sales commissions
$1.8M
Placement agents
H.C. Wainwright & Co., LLC3
First sale
Jan 2021
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2MraisedJul 2020 · 3 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Joseph TalamoExecutive Officer
  • Cynthia SchwalmDirector
  • Peter G. TraberDirector
  • Steven S. MyersDirector
  • Steven M. KloskDirector
  • David J. MazzoExecutive Officer, Director
  • Douglas LosordoExecutive Officer
  • Gregory B. BrownDirector
Offering amount
$2M
Amount sold
$2M
First sale
Jul 2020
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2.2MraisedJun 2020 · 6 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Douglas LosordoExecutive Officer
  • Peter G. TraberDirector
  • Gregory B. BrownDirector
  • Joseph TalamoExecutive Officer
  • David J. MazzoExecutive Officer
  • Steven S. MyersDirector
  • Cynthia SchwalmDirector
  • Steven M. KloskDirector
Offering amount
$2.2M
Amount sold
$2.2M
Sales commissions
$301K
Placement agents
H.C. Wainwright & Co., LLC
First sale
May 2020
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2.4MraisedMay 2020 · 5 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Peter G. TraberDirector
  • Steven M. KloskDirector
  • Gregory B. BrownDirector
  • Douglas LosordoExecutive Officer
  • Cynthia SchwalmDirector
  • David J. MazzoExecutive Officer
  • Joseph TalamoExecutive Officer
  • Steven S. MyersDirector
Offering amount
$2.4M
Amount sold
$2.4M
Sales commissions
$350K
Placement agents
H.C. Wainwright & Co., LLC
First sale
Apr 2020
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$12.6MraisedSep 2016 · 5 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • David MazzoExecutive Officer, Director
  • Peter TraberDirector
  • Douglas LosordoExecutive Officer
  • Joseph TalamoExecutive Officer
  • Andrew L. PecoraDirector
  • Steven M. KloskDirector
  • Richard BermanDirector
  • Steven S. MyersDirector
  • Eric WeiDirector
  • Robert A. PretiExecutive Officer, Director
Offering amount
$21M
Amount sold
$12.6M
First sale
Sep 2016
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1MraisedMar 2016 · 3 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • David J. MazzoExecutive Officer, Director
  • Steven S. MyersDirector
  • Joseph TalamoExecutive Officer
  • Peter TraberDirector
  • Robert A. PretiExecutive Officer, Director
  • Steven M. KloskDirector
  • Richard BermanDirector
  • Eric WeiDirector
  • Andrew L. PecoraDirector
Offering amount
$1M
Amount sold
$1M
First sale
Mar 2016
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$38MraisedMay 2014 · 142 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Robert PretiExecutive Officer
  • Stephen W. PotterExecutive Officer
  • Martyn D. GreenacreDirector
  • Robert Dickey IVExecutive Officer
  • Richard BermanDirector
  • Andrew L. PecoraExecutive Officer, Director
  • Catherine VaczyExecutive Officer
  • Joseph TalamoExecutive Officer
  • Douglas LosordoExecutive Officer
  • Drew BernsteinDirector
  • Steven S. MyersDirector
  • Eric H.C. WeiDirector
  • Robin L. SmithExecutive Officer, Director
Offering amount
$38M
Amount sold
$38M
Finders' fees
$1.5M
Placement agents
Piper Jaffray & Co.
First sale
May 2014
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

How much funding has Caladrius Biosciences raised?
Caladrius Biosciences has disclosed $83.2M raised across 7 rounds.
Where is Caladrius Biosciences headquartered?
Caladrius Biosciences is headquartered in Basking Ridge, US.